MCAM and melanoma: Changes in melanoma chondroitin sulfate proteoglycan (MCSP), melanoma cell adhesion molecule (MCAM) and other proteins were documented in EVs from patient-derived melanoma cell lines and conformed in melanoma patients receiving targeted therapy [7,10,13].